Depression, a common non-motor symptom of Parkinson's disease (PD), is accompanied by impaired 2 decision making and an enhanced response to aversive outcomes. Current strategies to treat depression 3 in PD include dopaminergic medication. However, their use can be accompanied by detrimental side 4 effects, such as enhanced risky choice. The mechanisms underlying dopamine-induced increases in risky 5 choice are unclear. In the current study we adopt a clinical-neuroeconomic approach to investigate the 6 effects of dopaminergic medication on loss aversion during risky choice in depressed and non-depressed 7 PD. Twenty-three healthy controls, 21 depressed and 22 non-depressed PD patients were assessed using 8 a well-established gambling task measuring loss aversion during risky choice. Patients were tested on 9 two occasions, after taking their normal dopaminergic medication (ON) and after withdrawal of their 10 medication (OFF). Dopaminergic medication decreased loss aversion to a greater extent in depressed 11 than non-depressed PD patients. Moreover, we show that the degree to which dopaminergic 12 medication decreases loss aversion correlated with current depression severity and with drug effects on 13 depression scores. These findings demonstrate that dopamine-induced changes in loss aversion depend 14 on the presence of depressive symptoms in PD. 15
Introduction

25
Depression is a common non-motor symptom of Parkinson's disease (PD) which greatly affects quality of 26 life (Schrag, 2006) . Similar to the motor symptoms, depression in PD can be treated with dopaminergic 27 medication (Barone et One mechanism by which dopaminergic medication can increase risky choice is by attenuating loss 32 aversion. Loss aversion reflects the relative weighting of gains and losses during risky choice and is one 33 of the core concepts of Prospect Theory, a well-known economic theory of decision-making under risk 34 Tversky, 1979, 1984) . In the domain of learning, dopamine manipulation studies in 35 healthy controls and PD patients have revealed that the balance between learning from reward and 36 punishment critically depends on striatal dopamine (Frank et Depression has been associated with reduced reward and enhanced punishment sensitivity across 44 various domains including decision making (Eshel and Roiser, 2010) . For instance, depressed individuals 45 (without PD) have been shown to exhibit reduced reward-based reversal learning and attenuation of 46 associated BOLD signal in the ventral striatum (Robinson et al., 2011) . Depressed patients also exhibit 47 7 felt over the past 24 hours, enabling us to assess dopaminergic drug (withdrawal) effects on depression 115 scores. Patients also completed the QUIP rating scale (Weintraub et al., 2012) Participants played a well-validated gambling task designed to measure loss aversion (Figure 1 ) (Tom et 124 al., 2007) . During this task, participants were presented with 169 mixed gambles (split into 3 runs) on a 125 computer screen. Each gamble offered a 50/50 percent chance of either gaining or losing varying 126 amounts of money. Potential gains ranged from +€6 to +€30 (increments of €2), potential losses ranged 127 from -€3 to -€15 (increments of €1). This asymmetric gain-loss range was chosen in order to maximize 128 statistical power, based on the assumption that on average people are twice as sensitive to losses as 129 they are to gains (Tom et al., 2007) . Each of the possible gain-loss pairs (13x13=169) was presented once 130 in randomized order. Participants were asked to either accept (play) or reject the gamble by pressing 131 one of two buttons. In order to make participants feel that they were gambling with their own money, 132 and thus avoid "house money effects" (Thaler and Johnson, 1990 ), endowments at the beginning of this 133 gambling task were earnings from a behavioral experiment immediately preceding the present 134 experiment on the same day. Gambles were not resolved during the experiment to exclude behavioral 135 adjustments on a trial-by-trial basis. However, participants were told to take each gamble seriously, is zero, choices are random, whereas if μ is highly positive or negative, there is consistency in choicebehavior, with a positive μ representing higher gamble acceptance with higher gain and lower loss value 172 (and vice versa for negative μ). We anticipated μ to be positive, consistent with a utility maximization 173 strategy, where participants accept more gambles when gain values increase and loss values decrease. 174
The constant parameter (c) reflects a response bias toward or away from gambling irrespective of the 175 value of the gambles. If c>0, there is a tendency to accept gambles regardless of their subjective utility. 176
If c<0, there is a tendency to reject gambles regardless of their subjective utility. 177
178
The model that we fitted to the data assumes a linear valuation of gains and losses, in contrast to the 179 curvilinear value function of Prospect Theory. This is a common and reasonable simplifying assumption 180
given the relatively narrow range of gains and losses used in this protocol. We also assumed no 181 subjective transformation of probabilities as described in Prospect Theory and thus assumed equal 182 weights for the 0.5 probability of gains and losses (Tom et and medication sessions cannot be attributed to parameter regularization employed during fitting, 209 because individual parameters from both patient groups (depressed and non-depressed) and both 210 sessions (ON and OFF medication) were obtained using the same a priori distribution (Huys et al., 2012) . 211
In a subsequent step, to compare PD patients with healthy controls, we fitted the model to healthy 212 control and patient data together (separately for each drug session). that penalizes complexity by marginalizing over both group and individual parameters using Laplace 221 approximation and Bayesian information criterion, respectively. The negative log-mode evidence 222 (NLME) was computed as: 223 
Statistical analysis 236
The primary parameter of interest was the loss aversion parameter (λ). First we compared depressed PD 237 patients with non-depressed PD patients. Subsequently we compared healthy controls with PD patients 238 (each group and drug session separately). For normally distributed data, we used a mixed ANOVA with 239 drug as within-subject and group as between-subject factor. For non-normally distributed data (Shapiro-240 13 Wilk, p<0.05) we used two-tailed Wilcoxon signed-rank tests to assess within-subject differences and 241
Mann Whitney tests to assess between-group differences. Two-tailed Pearson correlations were used 242 for normally distributed data and two-tailed Spearman correlations for non-normally distributed data. 243
Furthermore, for non-normally distributed data we reported medians and their standard error. Standard 244 errors of the median were computed using Bootstrapping (Efron et al., 1993 p<0.001, indicating significantly higher depression scores in the depressed patient group. There was no 255 main effect of drug (Figure 2A) . 256
Five patients exhibited at least one ICD as assessed with the QUIP rating scale (4 depressed and 1 non-257 depressed patient) but the proportion of ICD was not different between the two patient groups (Chi   2   258 test, p=0.14). None of them exhibited pathological gambling. Individual endowments at the beginning of 259 the task varied between participants, as these were earnings from a previous experiment performed on 260 the same day. However, there was no significant main effect of group or drug and no group*drug 261 interaction on these earnings. 262 The median loss aversion parameter per group and drug session can be found in Figure 2B . The loss 273 aversion parameter (λ) was not normally distributed as indicated by Shapiro-Wilk test. Therefore we 274 used nonparametric statistics. Our analyses revealed a significant group*drug interaction (U=149, 275 p=0.046), which was due to greater drug-induced decreases in loss aversion in depressed patients than 276 in non-depressed patients. If anything, medication increased loss aversion in non-depressed patients. 277
Effects of dopaminergic drugs on loss aversion
The simple main effects of drug were not significant. There was a near-significant effect of group in the 278 OFF state; depressed patients tended to be more loss-averse than non-depressed patients (U=151, 279 p=0.052). During the ON state there was no group effect (U=215, p=0.70). There was no overall main 280 effect of group (U=191, p=0.33) and no overall main effect of drug (Z=-0.21, p=0.84) ( Figure 2B ). There 281 were no effects of session order. To visualize drug and group effects on loss aversion, we plotted, for each group and drug session 293 separately, the degree to which the ratio of rejecting to accepting gambles increased as a function of 294 increases in potential losses (Figure 3) . To control for the effects of other factors, such as general drug 295 effects on gambling rate, we plotted the ratio of rejecting to accepting gambles as a function of relative 296 loss differences between pairs of trials, while the effects of different gains were averaged out. A steeper 297 slope indicates greater loss sensitivity. From this Figure 3 it is clear that dopaminergic medication had 298 contrasting effects on loss aversion in depressed and non-depressed PD patients. 299 
329
In a supplementary analysis we compared PD patients, each group and drug session separately, with 330 healthy controls. The median loss aversion parameter in healthy controls was significantly higher 331 compared with non-depressed patients OFF medication (U=150, p=0.019), but not different from non-332 depressed patients ON medication and depressed patients during both the ON and OFF session (Table  333 2). 334
335
Gambling response bias and inverse temperature parameter 336
The median gambling response bias and inverse temperature parameters are presented in Table 2 per 337 group and drug session. These parameters were not normally distributed as indicated by Shapiro-Wilk 338 test. We therefore used nonparametric statistics. Analyses of the gambling response bias parameter (c) 339
revealed that there were no main effects of drug (Z=-1.78, p=0.08) or group (U=199, p=0.44), and no 340 significant group*drug interaction (U=156, p=0.07). There were also no main effects of drug (Z=-.31, 341 p=0.75) or group (U=225, p=0.88) and no significant group*drug interaction (U=226, p=0.90) on the 342 inverse temperature parameter. 343
344
Relative to controls, non-depressed PD patients showed a significantly lower gambling response bias 345 during the OFF session (U=111, p=0.001), but not during the ON session (U=177, p=0.08). By contrast, 346 depressed PD patients showed a significantly lower gambling response bias during the ON session 347 (U=151, p=0.033), but not during the OFF session (U=160, p=0.06) relative to controls. There were no 348 differences in terms of the inverse temperature parameter (μ) between controls and either group of PD 349 patients (ON and OFF medication). 350
351
Proportion of accepted gambles 352
In addition to the computational parameters underlying risky choice, we analyzed the proportion of 353 accepted gambles, which is a compound measure of risky choice. 
Discussion
365
The present study shows that dopaminergic medication induced differential effects on loss aversion 366 during risky choice in PD patients with and without depression. Moreover, we demonstrate that the 367 degree to which medication reduces loss aversion correlates with current depression severity and with 368 drug effects on depression scores: drug-induced reductions in loss aversion were greater in more 369 severely depressed patients and in patients who exhibit greater medication-related decreases in 370 depression scores. 371
It is well known that dopaminergic treatment in PD patients can elicit detrimental side effects in the 372 domain of risky choice. In experimental settings, dopaminergic medication increases risky choice in PD 373 patients (Brand et al., 2004; Euteneuer et al., 2009 ), while also eliciting abnormal impulsive betting 374 behavior during decision making (Cools et al., 2003) . The present findings suggest that these effects 375 might have been driven by patients with relatively higher depression scores in the OFF medication state. 376
Critically, in those prior studies, the computational mechanisms underlying increased risky choice were 377 not investigated. In this study, we adopted a computational approach, enabling us to isolate the 378 mechanisms underlying drug-induced change during risky choice in (specific subgroups of) PD patients. In prior work, we have put forward the dopamine overdose hypothesis to account for the detrimental 387 effects of dopaminergic medication on punishment-based learning and decision-making. This hypothesis 388 states that dopaminergic medication doses necessary to remedy dopamine levels in severely depleted 389 dorsal striatum might detrimentally overdose dopamine levels in the relatively intact ventral striatum 390 (Cools et al., 2001 (Cools et al., , 2003 Cools, 2006) . According to this hypothesis, one might expect that any abnormal 391 decrease in loss aversion is seen only in non-depressed PD patients with a putatively intact ventral 392 striatum, while not extending to depressed PD patients, who have been argued to exhibit ventral striatal 393 dopamine deficiency (Vriend et al., 2014) . By contrast, the current study suggests that depressed PD 394 ICD has yet to be established (Voon et al., 2011a; Giorgetta et al., 2014) . 399 pattern of medication effects in terms of the proportion of accepted gambles, which did not exhibit a 424 significant drug*group effect, is quite different from that in terms of the loss aversion parameter, which 425 did exhibit a significant drug*group effect. This is not surprising because our model takes into account 426 the prior theoretical insight that the proportion of accepted gambles is a function of multiple 427 parameters, including not just loss aversion, but also gambling response bias. In fact, effects of 428 medication and depression on loss aversion were isolated, precisely because we disentangled it from 429 any (non significant) variability in terms of gambling response bias. As such, the discrepancy between 430 pattern of effects on the proportion of accepted gambles and that on loss aversion highlights the 431 strength of the adopted modeling approach. 
